Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.932 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9281 |
High Similarity |
NPD7075 |
Discontinued |
0.9211 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.9085 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9013 |
High Similarity |
NPD4380 |
Phase 2 |
0.8903 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8896 |
High Similarity |
NPD1934 |
Approved |
0.8882 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8844 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8844 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8784 |
High Similarity |
NPD1549 |
Phase 2 |
0.8774 |
High Similarity |
NPD6801 |
Discontinued |
0.8742 |
High Similarity |
NPD6799 |
Approved |
0.8726 |
High Similarity |
NPD3882 |
Suspended |
0.8718 |
High Similarity |
NPD2801 |
Approved |
0.8718 |
High Similarity |
NPD7819 |
Suspended |
0.8696 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8696 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8696 |
High Similarity |
NPD6166 |
Phase 2 |
0.8684 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8671 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8645 |
High Similarity |
NPD6599 |
Discontinued |
0.8627 |
High Similarity |
NPD1512 |
Approved |
0.859 |
High Similarity |
NPD7411 |
Suspended |
0.8581 |
High Similarity |
NPD1510 |
Phase 2 |
0.8544 |
High Similarity |
NPD3817 |
Phase 2 |
0.8523 |
High Similarity |
NPD2796 |
Approved |
0.8497 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8447 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8435 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8395 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8383 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8375 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8373 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8355 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8354 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8323 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8322 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8313 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8303 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8263 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8261 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8253 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8232 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8225 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8217 |
Intermediate Similarity |
NPD5403 |
Approved |
0.821 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8199 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8166 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8117 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8089 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8089 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8089 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8089 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8065 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8057 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8054 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7988 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7987 |
Intermediate Similarity |
NPD920 |
Approved |
0.7974 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7961 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7952 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7949 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7935 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7922 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7922 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7922 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7922 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7907 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7871 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7862 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7831 |
Intermediate Similarity |
NPD919 |
Approved |
0.7824 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7815 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7805 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.78 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7798 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7771 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7756 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7742 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7742 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7736 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7722 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD943 |
Approved |
0.7687 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7683 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7673 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7667 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7667 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7662 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7657 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7657 |
Intermediate Similarity |
NPD8312 |
Approved |
0.765 |
Intermediate Similarity |
NPD6776 |
Approved |
0.765 |
Intermediate Similarity |
NPD6777 |
Approved |
0.765 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.765 |
Intermediate Similarity |
NPD6778 |
Approved |
0.765 |
Intermediate Similarity |
NPD6781 |
Approved |
0.765 |
Intermediate Similarity |
NPD6780 |
Approved |
0.765 |
Intermediate Similarity |
NPD6779 |
Approved |
0.765 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7627 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7622 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7602 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7597 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7597 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7594 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7588 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7588 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7582 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7578 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7571 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7568 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7561 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7527 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7527 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7527 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7516 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7487 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7487 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7485 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7483 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7468 |
Intermediate Similarity |
NPD3268 |
Approved |
0.746 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7444 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7436 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7436 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7432 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7419 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7415 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7382 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7382 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7378 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7377 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7377 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7368 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7355 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7351 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7346 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7346 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7344 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7344 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7344 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7333 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.733 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7326 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7325 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7325 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7317 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.731 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7299 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.729 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.729 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7288 |
Intermediate Similarity |
NPD3823 |
Discontinued |
0.7287 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7278 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7253 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7246 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7239 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7237 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7232 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7219 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7219 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD37 |
Approved |
0.7216 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7215 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7211 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7193
|
Intermediate Similarity |
NPD4966 |
Approved |